EA200901100A1 - Производные 4-(пирролопиридинил)пиримидин-2-иламина - Google Patents

Производные 4-(пирролопиридинил)пиримидин-2-иламина

Info

Publication number
EA200901100A1
EA200901100A1 EA200901100A EA200901100A EA200901100A1 EA 200901100 A1 EA200901100 A1 EA 200901100A1 EA 200901100 A EA200901100 A EA 200901100A EA 200901100 A EA200901100 A EA 200901100A EA 200901100 A1 EA200901100 A1 EA 200901100A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrrolopiridinil
ilamin
pyrimidine
derivatives
inhibitors
Prior art date
Application number
EA200901100A
Other languages
English (en)
Inventor
Дитер Дорш
Кристиан Зирренберг
Томас Й.Й. Мюллер
Ойген Меркуль
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA200901100A1 publication Critical patent/EA200901100A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Соединения формулы (I), в которой R, R, R, Rи Rпринимают значения, описанные в п.1, представляют собой ингибиторы клеточной пролиферации/жизнеспособности клеток и могут быть использованы для лечения опухолей.
EA200901100A 2007-02-21 2008-01-28 Производные 4-(пирролопиридинил)пиримидин-2-иламина EA200901100A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007008419A DE102007008419A1 (de) 2007-02-21 2007-02-21 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
PCT/EP2008/000634 WO2008101587A1 (de) 2007-02-21 2008-01-28 4-(pyrrolopyridinyl)-pyrimidin-2-yl-amin-derivate

Publications (1)

Publication Number Publication Date
EA200901100A1 true EA200901100A1 (ru) 2010-02-26

Family

ID=39410261

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901100A EA200901100A1 (ru) 2007-02-21 2008-01-28 Производные 4-(пирролопиридинил)пиримидин-2-иламина

Country Status (18)

Country Link
US (2) US8293891B2 (ru)
EP (1) EP2121682B1 (ru)
JP (1) JP5508026B2 (ru)
KR (1) KR20090110948A (ru)
CN (1) CN101616918A (ru)
AR (1) AR065390A1 (ru)
AU (1) AU2008217297B2 (ru)
BR (1) BRPI0808167A2 (ru)
CA (1) CA2678691C (ru)
DE (1) DE102007008419A1 (ru)
DK (1) DK2121682T3 (ru)
EA (1) EA200901100A1 (ru)
ES (1) ES2427594T3 (ru)
IL (1) IL200470A (ru)
MX (1) MX2009008864A (ru)
PT (1) PT2121682E (ru)
WO (1) WO2008101587A1 (ru)
ZA (1) ZA200906539B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007140263A2 (en) * 2006-05-26 2007-12-06 University Of Louisville Research Foundation, Inc. Macrophage migration inhibitory factor antagonists and methods of using same
EP2480235A4 (en) 2009-09-24 2013-05-08 Univ Louisville Res Found NEW IODO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES AND SUFFERING IN CONNECTION WITH THE MACROPHAGE MIGRATION-INHIBITING FACTOR
WO2011146824A1 (en) 2010-05-20 2011-11-24 University Of Louisville Research Foundation, Inc. Methods and compositions for modulating ocular damage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
KR100983997B1 (ko) * 2001-01-09 2010-09-28 메르크 파텐트 게엠베하 수용체 타이로신 키나아제 저해제 및 혈관형성 저해제를 사용하는 병용 요법
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
WO2006038001A1 (en) * 2004-10-06 2006-04-13 Celltech R & D Limited Aminopyrimidine derivatives as jnk inhibitors

Also Published As

Publication number Publication date
ZA200906539B (en) 2010-06-30
MX2009008864A (es) 2009-08-28
PT2121682E (pt) 2013-10-17
US20110092527A1 (en) 2011-04-21
JP5508026B2 (ja) 2014-05-28
EP2121682A1 (de) 2009-11-25
WO2008101587A1 (de) 2008-08-28
EP2121682B1 (de) 2013-07-10
AU2008217297B2 (en) 2013-01-17
AR065390A1 (es) 2009-06-03
US8557977B2 (en) 2013-10-15
CN101616918A (zh) 2009-12-30
US8293891B2 (en) 2012-10-23
IL200470A (en) 2014-02-27
DK2121682T3 (da) 2013-09-08
JP2010519230A (ja) 2010-06-03
KR20090110948A (ko) 2009-10-23
IL200470A0 (en) 2010-04-29
CA2678691C (en) 2015-09-08
AU2008217297A1 (en) 2008-08-28
US20120264999A1 (en) 2012-10-18
DE102007008419A1 (de) 2008-08-28
ES2427594T3 (es) 2013-10-31
BRPI0808167A2 (pt) 2014-07-08
CA2678691A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
EA201100125A1 (ru) Производные пирролопиридинилпиримидин-2-иламина
EA201000004A1 (ru) Производные 6-(пирролопиридинил)пиримидин-2-иламина и их применение для лечения злокачественного новообразования и спида
EA201200119A1 (ru) Гетероциклические соединения в качестве ингибиторов аутотаксина
EA201300873A1 (ru) Производные 7-азаиндола
EA201101399A1 (ru) Гетероциклические соединения в качестве ингибиторов аутотаксина
EA201100880A1 (ru) Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина
EA201000094A1 (ru) Производные пиримидинил-пиридазинона
EA201200653A1 (ru) Гетариламинохинолины
EA201000549A1 (ru) Производные пиперидина и пиперазина
EA201001005A1 (ru) Производные 2-бензилпиридазинона в качестве ингибиторов мет киназы
EA200901601A1 (ru) Производные пиридазинона
EA201100966A1 (ru) Производные пиридазинона
EA201000558A1 (ru) Производные имидазола
EA200901611A1 (ru) Производные 2-оксо-3-бензил-бензоксазол-2-она и родственные соединения в качестве ингибиторов мет киназы для лечения опухолей
EA201201170A1 (ru) Гетариламинонафтиридины
EA201101585A1 (ru) 3-(1,2,3-триазол-4-ил)пирроло[2,3-b]пиридинпроизводные
EA201001648A1 (ru) Производные пиридазинона
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA201000550A1 (ru) Производные тиазола
EA201300442A1 (ru) ПИРРОЛИДИНОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ MetAP-2
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
EA201201081A1 (ru) Производные гетарил[1,8]нафтиридина
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA200901603A1 (ru) Арил-эфирные производные пиридазинона
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов